JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total International Bond ETF
BNDX
|
+$2.3B |
| 2 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$1.64B |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.55B |
| 4 |
iShares MBS ETF
MBB
|
+$1.29B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.14B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$693M |
| 2 |
CVS Health
CVS
|
+$676M |
| 3 |
Johnson & Johnson
JNJ
|
+$669M |
| 4 |
Mondelez International
MDLZ
|
+$593M |
| 5 |
UnitedHealth
UNH
|
+$572M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.25% |
| 2 | Technology | 12.49% |
| 3 | Financials | 12.17% |
| 4 | Healthcare | 9.9% |
| 5 | Consumer Discretionary | 8.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1651
Lamar Advertising Co
LAMR
$14.6B
| $15.7M | ﹤0.01% |
198,406
-10,513
| -5% | -$795K |
2013 Q2
23 quarters
|
|
|
CGC
1652
Canopy Growth
CGC
$374M
| $15.7M | ﹤0.01% |
36,175
+1,296
| +4% | +$568K |
2018 Q2
3 quarters
|
|
1653
TriCo Bancshares
TCBK
$1.67B
| $15.7M | ﹤0.01% |
398,565
-126,864
| -24% | -$4.79M |
2014 Q4
17 quarters
|
|
1654
Atmos Energy
ATO
$26.7B
| $15.7M | ﹤0.01% |
152,105
-29,947
| -16% | -$2.92M |
2013 Q2
23 quarters
|
|
1655
iShares MSCI EAFE Growth ETF
EFG
$15.2B
| $15.7M | ﹤0.01% |
202,070
-32,353
| -14% | -$2.4M |
2013 Q2
23 quarters
|
|
|
WAGE
1656
DELISTED
WageWorks, Inc.
WAGE
| $15.6M | ﹤0.01% |
414,373
-378,863
| -48% | -$12.4M |
2013 Q2
23 quarters
|
|
1657
iShares MSCI Indonesia ETF
EIDO
$423M
| $15.6M | ﹤0.01% |
609,096
-653,265
| -52% | -$17.2M |
2014 Q4
17 quarters
|
|
1658
Nice
NICE
$6.79B
| $15.6M | ﹤0.01% |
127,440
+1,549
| +1% | +$175K |
2015 Q1
16 quarters
|
|
1659
CALL
Constellation Brands
STZ
$19.4B
| $15.6M | ﹤0.01% |
88,900
-714,100
| -89% | -$120M |
2018 Q1
4 quarters
|
|
1660
Invesco S&P 500 High Dividend Low Volatility ETF
SPHD
$3.17B
| $15.6M | ﹤0.01% |
366,799
+54,338
| +17% | +$2.24M |
2016 Q1
12 quarters
|
|
1661
Whirlpool
WHR
$1.96B
| $15.6M | ﹤0.01% |
117,087
-92,033
| -44% | -$12.2M |
2013 Q2
23 quarters
|
|
1662
PUT
Cigna
CI
$71.7B
| $15.5M | ﹤0.01% |
96,624
-315,868
| -77% | -$57.7M |
2017 Q3
6 quarters
|
|
1663
PUT
Pfizer
PFE
$156B
| $15.5M | ﹤0.01% |
385,132
-730,211
| -65% | -$29.2M |
2013 Q2
23 quarters
|
|
|
BRW
1664
Saba Capital Income & Opportunities Fund
BRW
$303M
| $15.5M | ﹤0.01% |
1,621,897
-901,500
| -36% | -$8.53M |
2013 Q2
23 quarters
|
|
|
SCHW
1665
CALL
Charles Schwab
SCHW
$169B
| $15.5M | ﹤0.01% |
362,500
+139,300
| +62% | +$6.29M |
2017 Q3
6 quarters
|
|
|
IFFT
1666
DELISTED
International Flavors & Fragrances Inc. 6.00% Tangible Equity Units
IFFT
| $15.5M | ﹤0.01% |
309,578
+224,065
| +262% | +$11.5M |
2018 Q4
1 quarter
|
|
1667
Bio-Rad Laboratories Class A
BIO
$10.2B
| $15.4M | ﹤0.01% |
50,511
+5,122
| +11% | +$1.38M |
2013 Q2
23 quarters
|
|
1668
iShares MSCI Malaysia ETF
EWM
$285M
| $15.4M | ﹤0.01% |
515,370
+54,198
| +12% | +$1.65M |
2013 Q2
23 quarters
|
|
1669
CALL
Baidu
BIDU
$29.6B
| $15.4M | ﹤0.01% |
93,600
-701,000
| -88% | -$117M |
2016 Q1
12 quarters
|
|
1670
PUT
United Therapeutics
UTHR
$23B
| $15.4M | ﹤0.01% |
+131,100
| New | +$15.3M |
2019 Q1
0 quarters
|
|
1671
Invesco S&P Spin-Off ETF
CSD
$217M
| $15.4M | ﹤0.01% |
305,230
-5,645
| -2% | -$275K |
2018 Q2
3 quarters
|
|
1672
PUT
MetLife
MET
$61.6B
| $15.3M | ﹤0.01% |
360,000
-232,200
| -39% | -$10.3M |
2016 Q3
10 quarters
|
|
1673
CALL
Walmart Inc
WMT
$834B
| $15.3M | ﹤0.01% |
471,000
+192,600
| +69% | +$6.24M |
2016 Q2
11 quarters
|
|
1674
Alerian MLP ETF
AMLP
$12.9B
| $15.2M | ﹤0.01% |
303,734
-158,485
| -34% | -$7.77M |
2013 Q2
23 quarters
|
|
1675
PUT
State Street Health Care Select Sector SPDR ETF
XLV
$43.1B
| $15.2M | ﹤0.01% |
165,900
+5,900
| +4% | +$532K |
2016 Q4
9 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2019 Portfolio in Review
As of Q1 2019, JP Morgan Chase held 6,314 positions worth $490B, up 13% from $432B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q1 2019 filing shows 537 new, 2,080 increased, 2,670 reduced and 537 closed positions. Its largest new stake was Lyft: 2,510,596 shares worth $197M. The largest sale was Apple, an estimated $693M.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 26% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q1 2019 buy was Lyft: 2,510,596 shares worth $197M.
- JP Morgan Chase added most to Vanguard Total International Bond ETF in Q1 2019, an estimated $2.3B increase.
- JP Morgan Chase's biggest Q1 2019 reduction was Apple, cutting an estimated $693M.
- JP Morgan Chase fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $164M.
- JP Morgan Chase's ten largest holdings make up 16% of its $490B portfolio in Q1 2019.
- JP Morgan Chase opened 537 new positions and closed 537 in Q1 2019.
- JP Morgan Chase's portfolio value rose 13% quarter-over-quarter to $490B.
Based on JP Morgan Chase's 13F filing for Q1 2019, filed 7 May 2019.